Coordinatore | KAROLINSKA INSTITUTET
Organization address
address: Nobels Vag 5 contact info |
Nazionalità Coordinatore | Sweden [SE] |
Sito del progetto | http://www.eurocanplatform.eu/ |
Totale costo | 15˙561˙005 € |
EC contributo | 11˙998˙454 € |
Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
Code Call | FP7-HEALTH-2010-single-stage |
Funding Scheme | NoE |
Anno di inizio | 2011 |
Periodo (anno-mese-giorno) | 2011-01-01 - 2016-12-31 |
# | ||||
---|---|---|---|---|
1 |
KAROLINSKA INSTITUTET
Organization address
address: Nobels Vag 5 contact info |
SE (STOCKHOLM) | coordinator | 1˙708˙115.00 |
2 |
STICHTING HET NEDERLANDS KANKER INSTITUUT
Organization address
address: PLESMANLAAN 121 contact info |
NL (AMSTERDAM) | participant | 1˙869˙613.00 |
3 |
EUROPEAN MOLECULAR BIOLOGY LABORATORY
Organization address
address: Meyerhofstrasse 1 contact info |
DE (HEIDELBERG) | participant | 964˙456.00 |
4 |
DEUTSCHES KREBSFORSCHUNGSZENTRUM
Organization address
address: Im Neuenheimer Feld 280 contact info |
DE (HEIDELBERG) | participant | 787˙705.00 |
5 |
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
Organization address
address: The Old Schools, Trinity Lane contact info |
UK (CAMBRIDGE) | participant | 766˙700.00 |
6 |
CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER
Organization address
address: Cours Albert-Thomas 150 contact info |
FR (LYON CEDEX 08) | participant | 725˙100.00 |
7 |
OSLO UNIVERSITETSSYKEHUS HF
Organization address
address: FORSKNINGSVEIEN 2B contact info |
NO (OSLO) | participant | 647˙900.00 |
8 |
KRAEFTENS BEKAEMPELSE
Organization address
address: Strandboulevarden 49 contact info |
DK (KOEBENHAVN) | participant | 625˙688.00 |
9 |
FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI
Organization address
address: Via Venezian 1 contact info |
IT (Milan) | participant | 560˙300.00 |
10 |
INSTITUT CURIE
Organization address
address: 26, rue d'Ulm contact info |
FR (PARIS) | participant | 541˙022.00 |
11 |
INSTITUT GUSTAVE ROUSSY
Organization address
address: Rue Camille Desmoulins 39 contact info |
FR (VILLEJUIF) | participant | 479˙200.00 |
12 |
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Organization address
address: 's Gravendijkwal 230 contact info |
NL (ROTTERDAM) | participant | 310˙200.00 |
13 |
ecancermedicalscience AG
Organization address
address: c/o Bruno Wanner Management, Gotthardstrasse 20 contact info |
CH (Zug) | participant | 307˙997.00 |
14 |
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON
Organization address
city: Barcelona contact info |
ES (Barcelona) | participant | 260˙333.00 |
15 |
INSTITUTE OF CANCER RESEARCH - ROYAL CANCER HOSPITAL
Organization address
address: Old Brompton Road 123 contact info |
UK (LONDON) | participant | 225˙600.00 |
16 |
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III
Organization address
address: CALLE MELCHOR FERNANDEZ ALMAGRO 3 contact info |
ES (MADRID) | participant | 197˙700.00 |
17 |
ISTITUTO EUROPEO DI ONCOLOGIA SRL
Organization address
address: Via Filodrammatici 10 contact info |
IT (MILANO) | participant | 144˙800.00 |
18 |
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Organization address
address: University Offices, Wellington Square contact info |
UK (OXFORD) | participant | 135˙600.00 |
19 |
GROUPEMENT EUROPEEN D INTERET ECONOMIQUE ORGANISATION OF EUROPEAN CANCER INSTITUTES OECI
Organization address
address: RUE D EGMONT 11 11 contact info |
BE (Brussels) | participant | 122˙200.00 |
20 |
THE CHRISTIE NHS FOUNDATION TRUST
Organization address
address: WILMSLOW ROAD 1 contact info |
UK (MANCHESTER) | participant | 105˙600.00 |
21 |
Orszagos Onkologiai Intezet
Organization address
address: RATH GYORGY UTCA 7-9. contact info |
HU (Budapest) | participant | 84˙525.00 |
22 |
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL
Organization address
address: Avenue E. Mounier 83 contact info |
BE (Brussels) | participant | 81˙600.00 |
23 |
EUROPEAN CANCER PATIENT COALITION
Organization address
address: CHURCHILLLAAN 11-2 contact info |
NL (UTRECHT) | participant | 73˙800.00 |
24 |
ACADEMISCH ZIEKENHUIS LEIDEN
Organization address
address: Albinusdreef 2 contact info |
NL (LEIDEN) | participant | 69˙600.00 |
25 |
INSTITUTO TUMORI GIOVANNI PAOLO II
Organization address
address: VIA SAMUEL HAHNEMANN 10 contact info |
IT (BARI) | participant | 66˙710.00 |
26 |
Institut Jules Bordet
Organization address
city: Brussels contact info |
BE (Brussels) | participant | 51˙600.00 |
27 |
European CanCer Organisation
Organization address
address: Avenue E. Mounier 83 contact info |
BE (Brussels) | participant | 50˙590.00 |
28 |
Nome Ente NON disponibile
Organization address
city: VALENCIA contact info |
ES (VALENCIA) | participant | 34˙200.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Europe has a number of advantages as regards developing translational cancer research, yet there is no clear European strategy to meet the increasing burden posed by cancer. The FP6 EurocanPlus project analysed the barriers underlying the increasing fragmentation of cancer research and stressed the need to improve collaboration between basic/preclinical and comprehensive cancer centres (CCCs), institutions in which care and prevention is integrated with research and education. Furthermore, it proposed the creation of a platform of interlinked cancer centres with shared infrastructures and collaborative projects to facilitate rapid advances in knowledge, and their translation into better cancer care.
In response to these challenges and in line with the call, EurocanPlatform will work towards the goal of decreasing cancer mortality by dealing with three main areas of strategic research: prevention, early detection and improved treatments. It will build the necessary resources and know-how for the entire research continuum: basic research, early and late translational research, clinical research, epidemiological research, implementation in care and population based outcome research. There will be a strong focus on discovery-driven translational cancer research in five selected tumours: breast, head-neck, lung, malignant melanoma and pancreatic cancer. Joint structures and programmes for early detection will contribute to optimal treatment, and novel prevention research programmes will integrate prevention activities in clinical cancer centres as well as public prevention. Collaborations will also include molecular pathway-driven clinical research supported by joint structures for omics, biobanking and biomarker validation to support clinical trials aimed at enhancing patient benefits by individualised treatments.
EurocanPlatform is unique in its nature and represents a commitment from cancer centres to join forces and resources in order to fight cancer.
Cancer is one of the major health issues affecting our society and its incidence is predicted to increase globally as the population ages. There is an urgent need for improving cooperation between pre-clinical and comprehensive cancer centres in order to integrate care and prevention with research and education.